TreeWAS – Variant ID: rs17695224

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M79.6 Pain in limb	0.000	0.594	0.406
M79.67 Pain in limb (Ankle and foot)	0.000	0.598	0.402
M79.60 Pain in limb (Multiple sites)	0.000	0.605	0.395
M79.65 Pain in limb (Pelvic region and thigh)	0.000	0.607	0.393
M79.64 Pain in limb (Hand)	0.000	0.613	0.387
M79.66 Pain in limb (Lower leg)	0.000	0.685	0.315
M79.68 Pain in limb (Other)	0.000	0.697	0.303
M79.63 Pain in limb (Forearm)	0.000	0.719	0.281
M79.69 Pain in limb (Site unspecified)	0.000	0.770	0.230
M79 Other soft tissue disorders, not elsewhere classified	0.000	0.775	0.225
M79.2 Neuralgia and neuritis, unspecified	0.000	0.781	0.219
M79.1 Myalgia	0.000	0.792	0.208
M79.62 Pain in limb (Upper arm)	0.000	0.799	0.201
M79.19 Myalgia (Site unspecified)	0.000	0.805	0.195
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.000	0.806	0.194
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.813	0.187
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.000	0.819	0.181
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)	0.000	0.820	0.180
M79.5 Residual foreign body in soft tissue	0.000	0.820	0.180
M79.18 Myalgia (Other)	0.000	0.823	0.177
M79.61 Pain in limb (Shoulder region)	0.001	0.836	0.164
M79.26 Neuralgia and neuritis, unspecified (Lower leg)	0.000	0.837	0.163
M79.3 Panniculitis, unspecified	0.000	0.839	0.161
M79.16 Myalgia (Lower leg)	0.000	0.839	0.161
M79.24 Neuralgia and neuritis, unspecified (Hand)	0.000	0.843	0.157
M79.23 Neuralgia and neuritis, unspecified (Forearm)	0.000	0.843	0.157
M79.22 Neuralgia and neuritis, unspecified (Upper arm)	0.000	0.843	0.157
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)	0.000	0.843	0.157
M79.15 Myalgia (Pelvic region and thigh)	0.000	0.847	0.153
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)	0.000	0.849	0.151
M79.17 Myalgia (Ankle and foot)	0.000	0.851	0.149
M79.14 Myalgia (Hand)	0.000	0.851	0.149
M79.13 Myalgia (Forearm)	0.000	0.851	0.149
M79.12 Myalgia (Upper arm)	0.000	0.851	0.149
M79.54 Residual foreign body in soft tissue (Hand)	0.000	0.851	0.149
M79.4 Hypertrophy of (infrapatellar) fat pad	0.000	0.855	0.145
M79.9 Soft tissue disorder, unspecified	0.000	0.865	0.135
M79.56 Residual foreign body in soft tissue (Lower leg)	0.000	0.868	0.131
M79.58 Residual foreign body in soft tissue (Other)	0.000	0.870	0.129
M79.59 Residual foreign body in soft tissue (Site unspecified)	0.000	0.871	0.129
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)	0.000	0.871	0.129
M79.53 Residual foreign body in soft tissue (Forearm)	0.000	0.871	0.129
M79.52 Residual foreign body in soft tissue (Upper arm)	0.000	0.871	0.129
M79.51 Residual foreign body in soft tissue (Shoulder region)	0.000	0.871	0.129
M79.50 Residual foreign body in soft tissue (Multiple sites)	0.000	0.871	0.129
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.000	0.876	0.124
M79.10 Myalgia (Multiple sites)	0.000	0.882	0.118
M79.7 Fibromyalgia	0.000	0.883	0.117
M79.39 Panniculitis, unspecified (Site unspecified)	0.000	0.884	0.116
M79.38 Panniculitis, unspecified (Other)	0.000	0.884	0.116
M79.37 Panniculitis, unspecified (Ankle and foot)	0.000	0.884	0.116
M79.36 Panniculitis, unspecified (Lower leg)	0.000	0.884	0.116
M79.35 Panniculitis, unspecified (Pelvic region and thigh)	0.000	0.884	0.116
M79.34 Panniculitis, unspecified (Hand)	0.000	0.884	0.116
M79.33 Panniculitis, unspecified (Forearm)	0.000	0.884	0.116
M79.32 Panniculitis, unspecified (Upper arm)	0.000	0.884	0.116
M79.31 Panniculitis, unspecified (Shoulder region)	0.000	0.884	0.116
M79.30 Panniculitis, unspecified (Multiple sites)	0.000	0.884	0.116
M79.11 Myalgia (Shoulder region)	0.000	0.885	0.115
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec	0.000	0.896	0.104
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)	0.000	0.896	0.104
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)	0.000	0.896	0.104
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)	0.000	0.896	0.104
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)	0.000	0.896	0.104
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)	0.000	0.896	0.104
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)	0.000	0.896	0.104
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)	0.000	0.896	0.104
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)	0.000	0.896	0.104
M79.99 Soft tissue disorder, unspecified (Site unspecified)	0.000	0.901	0.099
M79.97 Soft tissue disorder, unspecified (Ankle and foot)	0.000	0.903	0.097
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)	0.000	0.903	0.097
M79.93 Soft tissue disorder, unspecified (Forearm)	0.000	0.903	0.097
M79.92 Soft tissue disorder, unspecified (Upper arm)	0.000	0.903	0.097
M79.91 Soft tissue disorder, unspecified (Shoulder region)	0.000	0.903	0.097
M79.90 Soft tissue disorder, unspecified (Multiple sites)	0.000	0.903	0.097
M79.98 Soft tissue disorder, unspecified (Other)	0.000	0.905	0.095
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.000	0.911	0.089
M79.70 Fibromyalgia (Multiple sites)	0.000	0.911	0.089
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.000	0.912	0.088
M79.78 Fibromyalgia (Other)	0.000	0.916	0.084
M79.77 Fibromyalgia (Ankle and foot)	0.000	0.916	0.084
M79.76 Fibromyalgia (Lower leg)	0.000	0.916	0.084
M79.75 Fibromyalgia (Pelvic region and thigh)	0.000	0.916	0.084
M79.74 Fibromyalgia (Hand)	0.000	0.916	0.084
M79.73 Fibromyalgia (Forearm)	0.000	0.916	0.084
M79.72 Fibromyalgia (Upper arm)	0.000	0.916	0.084
M79.71 Fibromyalgia (Shoulder region)	0.000	0.916	0.084
M79.94 Soft tissue disorder, unspecified (Hand)	0.000	0.919	0.080
H02.3 Blepharochalasis	0.072	0.928	0.000
H02 Other disorders of eyelid	0.069	0.931	0.000
H02.6 Xanthelasma of eyelid	0.066	0.934	0.000
H00 Hordeolum and chalazion	0.062	0.938	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.061	0.939	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.059	0.941	0.000
H00.1 Chalazion	0.059	0.941	0.000
H02.4 Ptosis of eyelid	0.057	0.943	0.000
H02.7 Other degenerative disorders of eyelid and periocular area	0.057	0.943	0.000
H02.1 Ectropion of eyelid	0.056	0.944	0.000
H02.5 Other disorders affecting eyelid function	0.055	0.945	0.000
H04.2 Epiphora	0.051	0.949	0.000
H04 Disorders of lachrymal system	0.050	0.950	0.000
H01 Other inflammation of eyelid	0.048	0.951	0.000
H01.0 Blepharitis	0.047	0.953	0.000
M79.0 Rheumatism, unspecified	0.000	0.956	0.044
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.957	0.043
H02.2 Lagophthalmos	0.042	0.958	0.000
H04.8 Other disorders of lachrymal system	0.042	0.958	0.000
H03 Disorders of eyelid in diseases classified elsewhere	0.040	0.960	0.000
H04.0 Dacryoadenitis	0.039	0.961	0.000
H02.0 Entropion and trichiasis of eyelid	0.039	0.961	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.962	0.038
H04.6 Other changes in lachrymal passages	0.036	0.963	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.036	0.964	0.000
H05 Disorders of orbit	0.033	0.967	0.000
H01.1 Non-infectious dermatoses of eyelid	0.033	0.967	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.968	0.032
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.968	0.032
M79.04 Rheumatism, unspecified (Hand)	0.000	0.968	0.032
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.968	0.032
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.968	0.032
H04.9 Disorder of lachrymal system, unspecified	0.031	0.969	0.000
M67 Other disorders of synovium and tendon	0.000	0.970	0.030
H04.5 Stenosis and insufficiency of lachrymal passages	0.030	0.970	0.000
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.971	0.029
M79.79 Fibromyalgia (Site unspecified)	0.000	0.971	0.029
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.028	0.971	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.028	0.971	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.971	0.028
M79.08 Rheumatism, unspecified (Other)	0.000	0.972	0.028
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.972	0.028
H01.9 Inflammation of eyelid, unspecified	0.027	0.973	0.000
T84.2 Mechanical complication of internal fixation device of other bones	0.000	0.973	0.027
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.973	0.027
H04.3 Acute and unspecified inflammation of lachrymal passages	0.026	0.974	0.000
H05.1 Chronic inflammatory disorders of orbit	0.026	0.974	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.026	0.974	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.026	0.974	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.026	0.974	0.000
H02.9 Disorder of eyelid, unspecified	0.026	0.974	0.000
M79.8 Other specified soft tissue disorders	0.000	0.974	0.026
M67.4 Ganglion	0.000	0.975	0.025
H04.4 Chronic inflammation of lachrymal passages	0.025	0.975	0.000
H05.4 Enophthalmos	0.025	0.975	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.024	0.976	0.000
H05.9 Disorder of orbit, unspecified	0.024	0.976	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.024	0.976	0.000
H05.3 Deformity of orbit	0.024	0.976	0.000
N30.9 Cystitis, unspecified	0.023	0.977	0.000
H05.8 Other disorders of orbit	0.023	0.977	0.000
M67.43 Ganglion, wrist	0.000	0.977	0.022
S61.1 Open wound of finger(s) with damage to nail	0.022	0.978	0.000
M67.9 Disorder of synovium and tendon, unspecified	0.000	0.978	0.022
M67.3 Transient synovitis	0.000	0.978	0.022
L73.9 Follicular disorder, unspecified	0.000	0.978	0.022
H02.8 Other specified disorders of eyelid	0.021	0.979	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.979	0.021
M79.80 Other specified soft tissue disorders (Multiple sites)	0.000	0.980	0.020
H01.8 Other specified inflammation of eyelid	0.020	0.980	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.000	0.981	0.019
M67.0 Short Achilles tendon (acquired)	0.000	0.981	0.019
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.000	0.981	0.019
H05.0 Acute inflammation of orbit	0.018	0.981	0.000
M67.49 Ganglion, multiple sites	0.000	0.982	0.018
M67.45 Ganglion, hip	0.000	0.982	0.018
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.982	0.018
H06.2 Dysthyroid exophthalmos	0.018	0.982	0.000
M67.1 Other contracture of tendon (sheath)	0.000	0.982	0.018
M67.47 Ganglion, ankle and foot	0.000	0.983	0.017
M79.81 Other specified soft tissue disorders (Shoulder region)	0.000	0.983	0.016
K35.9 Acute appendicitis, unspecified	0.000	0.984	0.016
S61.9 Open wound of wrist and hand, part unspecified	0.016	0.984	0.000
S61 Open wound of wrist and hand	0.016	0.984	0.000
M67.96 Unspecified disorder of synovium and tendon, lower leg	0.000	0.984	0.016
H05.2 Exophthalmic conditions	0.015	0.984	0.000
Y45.0 Opioids and related analgesics	0.014	0.986	0.000
M79.88 Other specified soft tissue disorders (Other)	0.000	0.986	0.014
M79.82 Other specified soft tissue disorders (Upper arm)	0.000	0.987	0.013
S61.7 Multiple open wounds of wrist and hand	0.013	0.987	0.000
H04.1 Other disorders of lachrymal gland	0.011	0.988	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.989	0.011
S61.0 Open wound of finger(s) without damage to nail	0.011	0.989	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.000	0.989	0.011
M79.83 Other specified soft tissue disorders (Forearm)	0.000	0.989	0.011
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.011	0.989	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.989	0.011
S22.40 Multiple fractures of ribs (closed)	0.000	0.990	0.010
S22.4 Multiple fractures of ribs	0.000	0.992	0.008
H43.1 Vitreous haemorrhage	0.008	0.992	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.007	0.993	0.000
K35 Acute appendicitis	0.000	0.993	0.007
S61.8 Open wound of other parts of wrist and hand	0.007	0.993	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.993	0.007
S22.2 Fracture of sternum	0.000	0.993	0.007
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.007	0.993	0.000
S22.20 Fracture of sternum (closed)	0.000	0.993	0.007
H16 Keratitis	0.007	0.993	0.000
H16.0 Corneal ulcer	0.007	0.993	0.000
Y42.5 Other oestrogens and progestogens	0.007	0.993	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
Y45.5 4-Aminophenol derivatives	0.006	0.993	0.000
Chapter VII Diseases of the eye and adnexa	0.006	0.994	0.000
H43.2 Crystalline deposits in vitreous body	0.006	0.994	0.000
S22.41 Multiple fractures of ribs (open)	0.000	0.994	0.006
H43 Disorders of vitreous body	0.006	0.994	0.000
S22.1 Multiple fractures of thoracic spine	0.000	0.994	0.006
Y45.4 Antirheumatics	0.006	0.994	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.994	0.006
J30.1 Allergic rhinitis due to pollen	0.000	0.994	0.006
J30.4 Allergic rhinitis, unspecified	0.000	0.994	0.006
K35.3 Acute appendicitis with localized peritonitis	0.000	0.994	0.006
H21 Other disorders of iris and ciliary body	0.006	0.994	0.000
H43-H45 Disorders of vitreous body and globe	0.006	0.994	0.000
H17 Corneal scars and opacities	0.006	0.994	0.000
H46 Optic neuritis	0.006	0.994	0.000
H18 Other disorders of cornea	0.006	0.994	0.000
J30 Vasomotor and allergic rhinitis	0.000	0.994	0.006
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.994	0.006
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
C79.6 Secondary malignant neoplasm of ovary	0.000	0.994	0.006
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
H16.2 Keratoconjunctivitis	0.006	0.994	0.000
K35.8 Acute appendicitis, other and unspecified	0.000	0.994	0.006
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.994	0.000
H21.8 Other specified disorders of iris and ciliary body	0.005	0.994	0.000
H55-H59 Other disorders of eye and adnexa	0.006	0.994	0.000
M22.4 Chondromalacia patellae	0.000	0.995	0.005
H46-H48 Disorders of optic nerve and visual pathways	0.005	0.995	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.995	0.005
S22.9 Fracture of bony thorax, part unspecified	0.000	0.995	0.005
S22.8 Fracture of other parts of bony thorax	0.000	0.995	0.005
S22.0 Fracture of thoracic vertebra	0.000	0.995	0.005
H16.3 Interstitial and deep keratitis	0.005	0.995	0.000
H20 Iridocyclitis	0.005	0.995	0.000
L73 Other follicular disorders	0.000	0.995	0.005
S22.21 Fracture of sternum (open)	0.000	0.995	0.005
S22.3 Fracture of rib	0.000	0.995	0.005
M65-M68 Disorders of synovium and tendon	0.000	0.995	0.005
J30.0 Vasomotor rhinitis	0.000	0.995	0.005
H16.4 Corneal neovascularisation	0.005	0.995	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.005	0.995	0.000
J30.3 Other allergic rhinitis	0.000	0.995	0.005
H17.8 Other corneal scars and opacities	0.005	0.995	0.000
H16.8 Other keratitis	0.005	0.995	0.000
H18.1 Bullous keratopathy	0.005	0.995	0.000
H18.7 Other corneal deformities	0.005	0.995	0.000
H18.2 Other corneal oedema	0.005	0.995	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
H18.4 Corneal degeneration	0.005	0.995	0.000
H20.8 Other iridocyclitis	0.005	0.995	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.005	0.995	0.000
H55 Nystagmus and other irregular eye movements	0.005	0.995	0.000
H43.0 Vitreous prolapse	0.005	0.995	0.000
C79 Secondary malignant neoplasm of other sites	0.000	0.995	0.005
S22.11 Multiple fractures of thoracic spine (open)	0.000	0.995	0.005
H16.9 Keratitis, unspecified	0.005	0.995	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.005	0.995	0.000
S22.5 Flail chest	0.000	0.995	0.005
H21.4 Pupillary membranes	0.005	0.995	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.005	0.995	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.005	0.995	0.000
Y42.4 Oral contraceptives	0.005	0.995	0.000
H17.9 Corneal scar and opacity, unspecified	0.005	0.995	0.000
H43.9 Disorder of vitreous body, unspecified	0.005	0.995	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.995	0.005
S27 Injury of other and unspecified intrathoracic organs	0.000	0.995	0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.004	0.995	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.004	0.995	0.000
S27.0 Traumatic pneumothorax	0.000	0.995	0.004
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.004	0.995	0.000
H17.1 Other central corneal opacity	0.004	0.996	0.000
H17.0 Adherent leukoma	0.004	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
H18.5 Hereditary corneal dystrophies	0.004	0.996	0.000
H18.3 Changes in corneal membranes	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.996	0.004
H15 Disorders of sclera	0.004	0.996	0.000
N04.9 Unspecified	0.000	0.996	0.004
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
H21.0 Hyphaema	0.004	0.996	0.000
H18.0 Corneal pigmentations and deposits	0.004	0.996	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.996	0.004
H21.2 Degeneration of iris and ciliary body	0.004	0.996	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.004	0.996	0.000
L40.9 Psoriasis, unspecified	0.000	0.996	0.004
H18.6 Keratoconus	0.004	0.996	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.004	0.996	0.000
S20-S29 Injuries to the thorax	0.000	0.996	0.004
S22.81 Fracture of other parts of bony thorax (open)	0.000	0.996	0.004
S22.80 Fracture of other parts of bony thorax (closed)	0.000	0.996	0.004
S22.91 Fracture of bony thorax, part unspecified (open)	0.000	0.996	0.004
S22.90 Fracture of bony thorax, part unspecified (closed)	0.000	0.996	0.004
S27.1 Traumatic haemothorax	0.000	0.996	0.004
S22.01 Fracture of thoracic vertebra (open)	0.000	0.996	0.004
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.996	0.004
H20.2 Lens-induced iridocyclitis	0.004	0.996	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.004	0.996	0.000
Y45.1 Salicylates	0.004	0.996	0.000
L73.1 Pseudofolliculitis barbae	0.000	0.996	0.004
L73.0 Acne keloid	0.000	0.996	0.004
H20.1 Chronic iridocyclitis	0.004	0.996	0.000
H43.3 Other vitreous opacities	0.004	0.996	0.000
M70-M79 Other soft tissue disorders	0.000	0.996	0.004
I24.9 Acute ischaemic heart disease, unspecified	0.004	0.996	0.000
S22.31 Fracture of rib (open)	0.000	0.996	0.004
M68 Disorders of synovium and tendon in diseases classified elsewhere	0.000	0.996	0.004
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.996	0.004
Y45.8 Other analgesics and antipyretics	0.004	0.996	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.004	0.996	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
Y41.5 Antiviral drugs	0.004	0.996	0.000
H57 Other disorders of eye and adnexa	0.004	0.996	0.000
S29 Other and unspecified injuries of thorax	0.000	0.996	0.004
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.004	0.996	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.004	0.996	0.000
Z73.3 Stress, not elsewhere classified	0.004	0.996	0.000
H11.0 Pterygium	0.004	0.996	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.004	0.996	0.000
S29.9 Unspecified injury of thorax	0.000	0.996	0.004
H18.9 Disorder of cornea, unspecified	0.004	0.996	0.000
L40.0 Psoriasis vulgaris	0.000	0.996	0.004
H10-H13 Disorders of conjunctiva	0.004	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.996	0.003
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.004	0.996	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.004	0.996	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.004	0.996	0.000
S27.2 Traumatic heamopneumothorax	0.000	0.996	0.004
N04 Nephrotic syndrome	0.000	0.996	0.004
S22.51 Flail chest (open)	0.000	0.996	0.003
Y45.2 Propionic acid derivatives	0.003	0.996	0.000
S27.8 Injury of other specified intrathoracic organs	0.000	0.996	0.004
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.003	0.996	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.003	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.996	0.000
M66 Spontaneous rupture of synovium and tendon	0.000	0.996	0.004
M77.12 Lateral epicondylitis (Upper arm)	0.000	0.996	0.004
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.996	0.004
S22.30 Fracture of rib (closed)	0.000	0.996	0.004
L73.2 Hidradenitis suppurativa	0.000	0.996	0.004
H20.9 Iridocyclitis, unspecified	0.004	0.996	0.000
S27.9 Injury of unspecified intrathoracic organ	0.000	0.996	0.003
S27.7 Multiple injuries of intrathoracic organs	0.000	0.996	0.003
S27.6 Injury of pleura	0.000	0.996	0.003
S27.5 Injury of thoracic trachea	0.000	0.996	0.003
S27.4 Injury of bronchus	0.000	0.996	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.996	0.003
H20.0 Acute and subacute iridocyclitis	0.003	0.996	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.003	0.996	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.003	0.996	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.003	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.996	0.000
H15.8 Other disorders of sclera	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
Z43.3 Attention to colostomy	0.000	0.997	0.003
S27.3 Other injuries of lung	0.000	0.997	0.003
H15.9 Disorder of sclera, unspecified	0.003	0.997	0.000
N05.9 Unspecified	0.000	0.997	0.003
H57.1 Ocular pain	0.003	0.997	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.003	0.997	0.000
I24.8 Other forms of acute ischaemic heart disease	0.003	0.997	0.000
J03.9 Acute tonsillitis, unspecified	0.000	0.997	0.003
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.997	0.003
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
N02 Recurrent and persistent haematuria	0.000	0.997	0.003
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.003	0.997	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.003	0.997	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.003	0.997	0.000
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.000	0.997	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.000	0.997	0.003
S26 Injury of heart	0.000	0.997	0.003
S25 Injury of blood vessels of thorax	0.000	0.997	0.003
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
N05 Unspecified nephritic syndrome	0.000	0.997	0.003
S24 Injury of nerves and spinal cord at thorax level	0.000	0.997	0.003
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
H15.0 Scleritis	0.003	0.997	0.000
M77.1 Lateral epicondylitis	0.000	0.997	0.003
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
N00-N08 Glomerular diseases	0.000	0.997	0.003
H57.0 Anomalies of pupillary function	0.003	0.997	0.000
L40 Psoriasis	0.000	0.997	0.003
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
M73 Soft tissue disorders in diseases classified elsewhere	0.000	0.997	0.003
Y58 Bacterial vaccines	0.003	0.997	0.000
H44 Disorders of globe	0.003	0.997	0.000
H57.8 Other specified disorders of eye and adnexa	0.003	0.997	0.000
M68.8 Other disorders of synovium and tendon in diseases classified elsewhere	0.000	0.997	0.003
M68.0 Synovitis and tenosynovitis in bacterial diseases classified elsewhere	0.000	0.997	0.003
N02.9 Unspecified	0.000	0.997	0.003
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.997	0.003
S29.8 Other specified injuries of thorax	0.000	0.997	0.003
S29.7 Multiple injuries of thorax	0.000	0.997	0.003
S29.0 Injury of muscle and tendon at thorax level	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
N02.8 Other	0.000	0.997	0.003
H59.0 Vitreous syndrome following cataract surgery	0.003	0.997	0.000
R18 Ascites	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)	0.000	0.997	0.003
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.000	0.997	0.003
S21 Open wound of thorax	0.000	0.997	0.003
N05.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
H13 Disorders of conjunctiva in diseases classified elsewhere	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
H40-H42 Glaucoma	0.003	0.997	0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.003	0.997	0.000
N04.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
N02.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
S22.50 Flail chest (closed)	0.000	0.997	0.003
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.000	0.997	0.003
N04.8 Other	0.000	0.997	0.003
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N04.6 Dense deposit disease	0.000	0.997	0.003
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.997	0.003
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.997	0.003
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.997	0.003
N04.0 Minor glomerular abnormality	0.000	0.997	0.003
M77 Other enthesopathies	0.000	0.997	0.003
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)	0.000	0.997	0.003
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.997	0.003
M66.5 Spontaneous rupture of unspecified tendon	0.000	0.997	0.003
M66.1 Rupture of synovium	0.000	0.997	0.003
M66.4 Spontaneous rupture of other tendons	0.000	0.997	0.003
H11 Other disorders of conjunctiva	0.003	0.997	0.000
N03 Chronic nephritic syndrome	0.000	0.997	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
S27.41 Injury of bronchus (with open wound into thoracic cavity)	0.000	0.997	0.003
S27.40 Injury of bronchus (without open wound into thoracic cavity)	0.000	0.997	0.003
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)	0.000	0.997	0.003
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)	0.000	0.997	0.003
S27.61 Injury of pleura (with open wound into thoracic cavity)	0.000	0.997	0.003
S27.60 Injury of pleura (without open wound into thoracic cavity)	0.000	0.997	0.003
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)	0.000	0.997	0.003
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)	0.000	0.997	0.003
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)	0.000	0.997	0.003
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)	0.000	0.997	0.003
N04.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
H15.1 Episcleritis	0.002	0.997	0.000
M66.0 Rupture of popliteal cyst	0.000	0.997	0.003
G95.9 Disease of spinal cord, unspecified	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
I82.2 Embolism and thrombosis of vena cava	0.000	0.997	0.003
M66.2 Spontaneous rupture of extensor tendons	0.000	0.997	0.003
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)	0.000	0.997	0.003
M66.3 Spontaneous rupture of flexor tendons	0.000	0.997	0.003
Q60.0 Renal agenesis, unilateral	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.997	0.003
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
C79.2 Secondary malignant neoplasm of skin	0.000	0.997	0.003
L40.5 Arthropathic psoriasis	0.000	0.997	0.003
M76 Enthesopathies of lower limb, excluding foot	0.000	0.997	0.003
H26.1 Traumatic cataract	0.003	0.997	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N02.6 Dense deposit disease	0.000	0.997	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations